In contrast to our results in dogs, in one study of 241 human patients, CD80 was expressed in 43 to 97% on B cell tumors, including diffuse large cell and marginal zone lymphoma (46), which are common subtypes of B cell tumors in dogs (47). Here, CD80 is linked to non-Hodgkin lymphoma.